SCHEMBL9954047

SCHEMBL9954047

COCCN.COCCn1c(NC#N)nc2ccc(Br)cc2c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.41
ALDH1A1 P00352 9/20 0.38
CYP3A4 P08684 4/20 0.36
CYP1A2 P05177 4/20 0.36
USP2 O75604 2/20 0.36
MEN1 O00255 1/20 0.36
CYP2D6 P10635 1/20 0.36
TSHR P16473 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
KMT2A Q03164 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
GHSR Q92847 4/20 0.36
CASP3 P42574 1/20 0.36
CYP2C9 P11712 2/20 0.35
KDM4E B2RXH2 3/20 0.35
MAPT P10636 2/20 0.35
HTT P42858 1/20 0.35
DPP4 P27487 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9955265 0.91 HSD17B10 (0.41) HSD17B10ALDH1A1CYP3A4CYP1A2USP2
SCHEMBL10289053 0.83 KDM4E (0.50) HSD17B10ALDH1A1CYP3A4CYP1A2USP2
SCHEMBL31241102 0.83 CACNA2D1 (0.42) ALDH1A1USP2MEN1KMT2ACASP3
SCHEMBL9953325 0.77 HSD17B10 (0.49) HSD17B10ALDH1A1CYP3A4CYP1A2MEN1
SCHEMBL9954166 0.76 ALDH1A1 (0.42) HSD17B10ALDH1A1MEN1TSHRCASP1
SCHEMBL9954454 0.74 MEN1 (0.41) HSD17B10ALDH1A1CYP3A4CYP1A2MEN1
SCHEMBL9954050 0.73 HSD17B10 (0.41) HSD17B10ALDH1A1CYP3A4CYP1A2USP2
SCHEMBL9955108 0.72 MEN1 (0.40) ALDH1A1CYP3A4MEN1KMT2ADPP4
SCHEMBL9954225 0.71 ALDH1A1 (0.52) ALDH1A1CYP3A4MEN1KMT2AKDM4E
SCHEMBL9953670 0.71 ALDH1A1 (0.44) ALDH1A1CYP3A4CYP1A2MEN1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed